Business Daily cover image

The weight-loss drug revolution

Business Daily

00:00

Developing a New Drug for Diabetes and Obesity

The chapter provides insights into the development process of CT388, a new drug intended to address type 2 diabetes and obesity, with potential broader applications and fewer side effects. The team discusses the multi-year timeline to bring the drug to market and their holistic approach to tackling complex metabolic issues.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app